For Immediate Release: April 24, 2019
Society for Healthcare Epidemiology of America
Contact: Tamara Moore / / 202-868-4008

New Infection Prevention and Control Training Opportunity for Clinicians in Development
Program looks to improve infection prevention and control best practices among frontline healthcare providers

Arlington, VA (April 24, 2019) — Today the Society for Healthcare Epidemiology of America (SHEA) announced the development of a new training course in best practices in infection prevention and control for hospital clinicians with direct patient care responsibilities. The online program, known as Prevention Course in HAI Knowledge and Control (Prevention CHKC), is supported by an educational grant from BD (Becton, Dickinson and Company) and was announced at SHEA’s Spring Meeting in Boston.

“Frontline hospital clinicians have an enormous responsibility for preventing healthcare-associated infections, but many may not have access to expert training on the best strategies for how to do this,” said Hilary Babcock, MD, MPH, President of SHEA. “Prevention CHKC is being created to make information from experts accessible and affordable for busy, practicing clinicians.”

While efforts to reduce healthcare-associated infections (HAIs) have been effective for certain infection types within specific care settings, HAIs still affect one in every 20 hospitalized patients, leading to morbidity, mortality, and excess healthcare costs. One cause may be persistent gaps between recommended infection prevention and control strategies and what is practiced.

“SHEA’s efforts to encourage clinicians to adopt best practices for infection prevention and control are critical to addressing the growing prevalence and threat of antimicrobial resistance, which can stem from HAIs,” said Gary Cohen, Executive Vice President, Global Health at BD and President, BD Foundation. “BD is supporting this important program to ensure its wide availability to nurses, pharmacists, physicians and infection preventionists as they all work to reduce HAIs and improve patient safety.”

SHEA is developing the Prevention CHKC program to address these knowledge gaps and improve the safety and quality of patient care provided by frontline healthcare personnel. The program will include 10-12 online, interactive modules authored by a Program Committee of multidisciplinary experts and will be focused initially on healthcare in acute care settings, such as hospitals, with the aim for the content to be adaptable for other care settings.

The training will help frontline personnel improve their understanding of their roles in HAI prevention. The program will include a special focus on:

  • Performing basic prevention strategies of hand hygiene and cleaning of the environment and equipment;
  • Recognizing and managing outbreaks;
  • Understanding strategies to prevent common HAIs, including central line-associated bloodstream infections, catheter-associated urinary tract infections, surgical site infections, ventilator-associated events, Clostridioides difficile infections, and methicillin-resistant Staphylococcus aureus (MRSA); and 
  • Developing performance and accountability measures to assess infection prevention practices.

Prevention CHKC is slated to launch in early 2020 as an easily-accessible and broadly available set of course modules for frontline healthcare personnel. SHEA is working to secure continuing education (CE) credits for those who successfully complete the program modules.


The Society for Healthcare Epidemiology of America (SHEA) is a professional society representing more than 2,000 physicians and other healthcare professionals around the world who possess expertise and passion for healthcare epidemiology, infection prevention, and antimicrobial stewardship. The society’s work improves public health by establishing infection-prevention measures and supporting antibiotic stewardship among healthcare providers, hospitals, and health systems. This is accomplished by leading research studies, translating research into clinical practice, developing evidence-based policies, optimizing antibiotic stewardship, and advancing the field of healthcare epidemiology. SHEA and its members strive to improve patient outcomes and create a safer, healthier future for all. Visit SHEA online at, and @SHEA_Epi.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit